nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Increased Diuresis—Hydrochlorothiazide—nephrolithiasis	0.583	1	CiPCiCtD
Indapamide—SLC12A3—Hydrochlorothiazide—nephrolithiasis	0.0752	0.235	CbGbCtD
Indapamide—CA5B—Hydrochlorothiazide—nephrolithiasis	0.0589	0.184	CbGbCtD
Indapamide—CA9—Hydrochlorothiazide—nephrolithiasis	0.0505	0.158	CbGbCtD
Indapamide—CA12—Hydrochlorothiazide—nephrolithiasis	0.0505	0.158	CbGbCtD
Indapamide—CA4—Hydrochlorothiazide—nephrolithiasis	0.0444	0.139	CbGbCtD
Indapamide—CA2—Hydrochlorothiazide—nephrolithiasis	0.0408	0.128	CbGbCtD
Indapamide—SLC12A3—loop of Henle—nephrolithiasis	0.0121	0.342	CbGeAlD
Indapamide—SLC12A3—collecting duct of renal tubule—nephrolithiasis	0.00686	0.194	CbGeAlD
Indapamide—SLC12A3—nephron—nephrolithiasis	0.00305	0.0864	CbGeAlD
Indapamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.0024	0.148	CbGpPWpGaD
Indapamide—Xanthopsia—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0523	CcSEcCtD
Indapamide—Angiitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0523	CcSEcCtD
Indapamide—CA2—collecting duct of renal tubule—nephrolithiasis	0.00234	0.0661	CbGeAlD
Indapamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.0023	0.142	CbGpPWpGaD
Indapamide—Vasculitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.00206	0.0456	CcSEcCtD
Indapamide—Sialoadenitis—Hydrochlorothiazide—nephrolithiasis	0.00176	0.0391	CcSEcCtD
Indapamide—KCNE1—renal system—nephrolithiasis	0.00121	0.0343	CbGeAlD
Indapamide—KCNE1—kidney—nephrolithiasis	0.00117	0.0332	CbGeAlD
Indapamide—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.00111	0.0247	CcSEcCtD
Indapamide—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.00103	0.0229	CcSEcCtD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.000921	0.0568	CbGpPWpGaD
Indapamide—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000878	0.0195	CcSEcCtD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.000842	0.0519	CbGpPWpGaD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.000842	0.0519	CbGpPWpGaD
Indapamide—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.000819	0.0182	CcSEcCtD
Indapamide—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.000819	0.0182	CcSEcCtD
Indapamide—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.000678	0.015	CcSEcCtD
Indapamide—SLC12A3—nephron tubule—nephrolithiasis	0.000659	0.0187	CbGeAlD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.000638	0.0393	CbGpPWpGaD
Indapamide—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.000638	0.0142	CcSEcCtD
Indapamide—CA7—renal system—nephrolithiasis	0.000612	0.0173	CbGeAlD
Indapamide—SLC12A3—renal system—nephrolithiasis	0.000599	0.017	CbGeAlD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.000594	0.0366	CbGpPWpGaD
Indapamide—CA7—kidney—nephrolithiasis	0.000591	0.0167	CbGeAlD
Indapamide—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000582	0.0129	CcSEcCtD
Indapamide—SLC12A3—kidney—nephrolithiasis	0.000579	0.0164	CbGeAlD
Indapamide—SLC12A3—cortex of kidney—nephrolithiasis	0.000564	0.016	CbGeAlD
Indapamide—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.000563	0.0125	CcSEcCtD
Indapamide—KCNQ1—renal system—nephrolithiasis	0.000557	0.0158	CbGeAlD
Indapamide—KCNQ1—kidney—nephrolithiasis	0.000538	0.0152	CbGeAlD
Indapamide—CYP3A4—urine—nephrolithiasis	0.000538	0.0152	CbGeAlD
Indapamide—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.000532	0.0118	CcSEcCtD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.000529	0.0326	CbGpPWpGaD
Indapamide—KCNQ1—cortex of kidney—nephrolithiasis	0.000524	0.0148	CbGeAlD
Indapamide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00049	0.0109	CcSEcCtD
Indapamide—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.000487	0.0108	CcSEcCtD
Indapamide—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.000464	0.0103	CcSEcCtD
Indapamide—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.000464	0.0103	CcSEcCtD
Indapamide—Gout—Hydrochlorothiazide—nephrolithiasis	0.000461	0.0102	CcSEcCtD
Indapamide—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00045	0.00998	CcSEcCtD
Indapamide—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.000441	0.00979	CcSEcCtD
Indapamide—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.000439	0.00973	CcSEcCtD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000412	0.0254	CbGpPWpGaD
Indapamide—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.000407	0.00902	CcSEcCtD
Indapamide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000404	0.00897	CcSEcCtD
Indapamide—CA12—renal system—nephrolithiasis	0.000397	0.0112	CbGeAlD
Indapamide—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.000394	0.00873	CcSEcCtD
Indapamide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00039	0.00864	CcSEcCtD
Indapamide—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00039	0.00864	CcSEcCtD
Indapamide—CA12—kidney—nephrolithiasis	0.000384	0.0109	CbGeAlD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000376	0.0232	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000376	0.0232	CbGpPWpGaD
Indapamide—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00036	0.00798	CcSEcCtD
Indapamide—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.000356	0.0079	CcSEcCtD
Indapamide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.000356	0.0079	CcSEcCtD
Indapamide—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.000353	0.00783	CcSEcCtD
Indapamide—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00035	0.00776	CcSEcCtD
Indapamide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000346	0.00769	CcSEcCtD
Indapamide—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.000337	0.00748	CcSEcCtD
Indapamide—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.000333	0.00738	CcSEcCtD
Indapamide—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.000331	0.00735	CcSEcCtD
Indapamide—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00033	0.00732	CcSEcCtD
Indapamide—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00033	0.00732	CcSEcCtD
Indapamide—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000324	0.0072	CcSEcCtD
Indapamide—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.000322	0.00714	CcSEcCtD
Indapamide—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000314	0.00697	CcSEcCtD
Indapamide—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00031	0.00688	CcSEcCtD
Indapamide—Migraine—Hydrochlorothiazide—nephrolithiasis	0.000308	0.00683	CcSEcCtD
Indapamide—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.000302	0.0067	CcSEcCtD
Indapamide—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.000294	0.00652	CcSEcCtD
Indapamide—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.000289	0.00641	CcSEcCtD
Indapamide—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.000286	0.00634	CcSEcCtD
Indapamide—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000286	0.00634	CcSEcCtD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000285	0.0176	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000285	0.0176	CbGpPWpGaD
Indapamide—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000285	0.00631	CcSEcCtD
Indapamide—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000282	0.00625	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.000282	0.00625	CcSEcCtD
Indapamide—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000277	0.00614	CcSEcCtD
Indapamide—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000276	0.00612	CcSEcCtD
Indapamide—CA4—nephron tubule—nephrolithiasis	0.000271	0.00766	CbGeAlD
Indapamide—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00027	0.006	CcSEcCtD
Indapamide—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00027	0.006	CcSEcCtD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000265	0.0163	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000265	0.0163	CbGpPWpGaD
Indapamide—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.000265	0.00588	CcSEcCtD
Indapamide—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000263	0.00584	CcSEcCtD
Indapamide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000253	0.00561	CcSEcCtD
Indapamide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00025	0.00554	CcSEcCtD
Indapamide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000249	0.00552	CcSEcCtD
Indapamide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000247	0.00547	CcSEcCtD
Indapamide—CA4—renal system—nephrolithiasis	0.000246	0.00696	CbGeAlD
Indapamide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000244	0.00541	CcSEcCtD
Indapamide—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000242	0.00538	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000239	0.0053	CcSEcCtD
Indapamide—CA4—kidney—nephrolithiasis	0.000238	0.00673	CbGeAlD
Indapamide—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000237	0.00526	CcSEcCtD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000236	0.0146	CbGpPWpGaD
Indapamide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000235	0.00521	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000235	0.0145	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000235	0.0145	CbGpPWpGaD
Indapamide—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000234	0.0052	CcSEcCtD
Indapamide—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000234	0.0052	CcSEcCtD
Indapamide—CA4—cortex of kidney—nephrolithiasis	0.000232	0.00656	CbGeAlD
Indapamide—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000231	0.00513	CcSEcCtD
Indapamide—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000226	0.00502	CcSEcCtD
Indapamide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000225	0.00499	CcSEcCtD
Indapamide—CA2—nephron tubule—nephrolithiasis	0.000224	0.00635	CbGeAlD
Indapamide—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000217	0.00481	CcSEcCtD
Indapamide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.000216	0.0048	CcSEcCtD
Indapamide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000215	0.00478	CcSEcCtD
Indapamide—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000215	0.00476	CcSEcCtD
Indapamide—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000213	0.00473	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000209	0.0129	CbGpPWpGaD
Indapamide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.000208	0.00463	CcSEcCtD
Indapamide—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000205	0.00454	CcSEcCtD
Indapamide—CA2—renal system—nephrolithiasis	0.000204	0.00577	CbGeAlD
Indapamide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000202	0.00448	CcSEcCtD
Indapamide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000201	0.00445	CcSEcCtD
Indapamide—CA2—kidney—nephrolithiasis	0.000197	0.00558	CbGeAlD
Indapamide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000193	0.00429	CcSEcCtD
Indapamide—CA2—cortex of kidney—nephrolithiasis	0.000192	0.00544	CbGeAlD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000191	0.0118	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000191	0.0118	CbGpPWpGaD
Indapamide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000188	0.00418	CcSEcCtD
Indapamide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000186	0.00412	CcSEcCtD
Indapamide—Tension—Hydrochlorothiazide—nephrolithiasis	0.000185	0.0041	CcSEcCtD
Indapamide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000184	0.00409	CcSEcCtD
Indapamide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000183	0.00406	CcSEcCtD
Indapamide—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000182	0.00404	CcSEcCtD
Indapamide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000181	0.00402	CcSEcCtD
Indapamide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000177	0.00394	CcSEcCtD
Indapamide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000175	0.00388	CcSEcCtD
Indapamide—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000174	0.00386	CcSEcCtD
Indapamide—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000173	0.00384	CcSEcCtD
Indapamide—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000172	0.00382	CcSEcCtD
Indapamide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00017	0.00377	CcSEcCtD
Indapamide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000169	0.00375	CcSEcCtD
Indapamide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000169	0.00375	CcSEcCtD
Indapamide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000169	0.00374	CcSEcCtD
Indapamide—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000166	0.00369	CcSEcCtD
Indapamide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000166	0.00367	CcSEcCtD
Indapamide—Cough—Hydrochlorothiazide—nephrolithiasis	0.000164	0.00365	CcSEcCtD
Indapamide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00016	0.00356	CcSEcCtD
Indapamide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00016	0.00356	CcSEcCtD
Indapamide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00016	0.00356	CcSEcCtD
Indapamide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00016	0.00354	CcSEcCtD
Indapamide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000158	0.00351	CcSEcCtD
Indapamide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000157	0.00348	CcSEcCtD
Indapamide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000154	0.00341	CcSEcCtD
Indapamide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000154	0.00341	CcSEcCtD
Indapamide—Shock—Hydrochlorothiazide—nephrolithiasis	0.000151	0.00335	CcSEcCtD
Indapamide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00015	0.00334	CcSEcCtD
Indapamide—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00015	0.00333	CcSEcCtD
Indapamide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000149	0.0033	CcSEcCtD
Indapamide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000147	0.00325	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000145	0.00893	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000145	0.00893	CbGpPWpGaD
Indapamide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000144	0.00319	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00014	0.00311	CcSEcCtD
Indapamide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000139	0.00308	CcSEcCtD
Indapamide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000138	0.00306	CcSEcCtD
Indapamide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000137	0.00304	CcSEcCtD
Indapamide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000137	0.00303	CcSEcCtD
Indapamide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000135	0.003	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000135	0.00831	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000135	0.00831	CbGpPWpGaD
Indapamide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000134	0.00296	CcSEcCtD
Indapamide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000133	0.00294	CcSEcCtD
Indapamide—CYP3A4—renal system—nephrolithiasis	0.000132	0.00372	CbGeAlD
Indapamide—Pain—Hydrochlorothiazide—nephrolithiasis	0.000131	0.00292	CcSEcCtD
Indapamide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000131	0.00292	CcSEcCtD
Indapamide—CYP3A4—kidney—nephrolithiasis	0.000127	0.0036	CbGeAlD
Indapamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000127	0.00281	CcSEcCtD
Indapamide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000126	0.00279	CcSEcCtD
Indapamide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000122	0.00271	CcSEcCtD
Indapamide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000122	0.0027	CcSEcCtD
Indapamide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000122	0.0027	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00012	0.0074	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00012	0.0074	CbGpPWpGaD
Indapamide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000113	0.00251	CcSEcCtD
Indapamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00011	0.00245	CcSEcCtD
Indapamide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000109	0.00241	CcSEcCtD
Indapamide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000105	0.00233	CcSEcCtD
Indapamide—CA5A—Metabolism—GRHPR—nephrolithiasis	0.000104	0.00642	CbGpPWpGaD
Indapamide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000102	0.00225	CcSEcCtD
Indapamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	9.77e-05	0.00217	CcSEcCtD
Indapamide—CA7—Metabolism—GRHPR—nephrolithiasis	9.73e-05	0.00599	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GRHPR—nephrolithiasis	9.73e-05	0.00599	CbGpPWpGaD
Indapamide—Rash—Hydrochlorothiazide—nephrolithiasis	9.69e-05	0.00215	CcSEcCtD
Indapamide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	9.68e-05	0.00215	CcSEcCtD
Indapamide—Headache—Hydrochlorothiazide—nephrolithiasis	9.63e-05	0.00214	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	9.6e-05	0.00592	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AGXT—nephrolithiasis	9.29e-05	0.00572	CbGpPWpGaD
Indapamide—Nausea—Hydrochlorothiazide—nephrolithiasis	9.13e-05	0.00203	CcSEcCtD
Indapamide—CA12—Metabolism—GRHPR—nephrolithiasis	9.01e-05	0.00555	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AGXT—nephrolithiasis	8.67e-05	0.00534	CbGpPWpGaD
Indapamide—CA7—Metabolism—AGXT—nephrolithiasis	8.67e-05	0.00534	CbGpPWpGaD
Indapamide—CA12—Metabolism—AGXT—nephrolithiasis	8.03e-05	0.00495	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC26A1—nephrolithiasis	7.9e-05	0.00487	CbGpPWpGaD
Indapamide—CA5A—Metabolism—APRT—nephrolithiasis	7.9e-05	0.00487	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC26A1—nephrolithiasis	7.37e-05	0.00454	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC26A1—nephrolithiasis	7.37e-05	0.00454	CbGpPWpGaD
Indapamide—CA7—Metabolism—APRT—nephrolithiasis	7.37e-05	0.00454	CbGpPWpGaD
Indapamide—CA5B—Metabolism—APRT—nephrolithiasis	7.37e-05	0.00454	CbGpPWpGaD
Indapamide—CA4—Metabolism—GRHPR—nephrolithiasis	7.19e-05	0.00443	CbGpPWpGaD
Indapamide—CA2—Metabolism—GRHPR—nephrolithiasis	6.89e-05	0.00425	CbGpPWpGaD
Indapamide—CA12—Metabolism—APRT—nephrolithiasis	6.83e-05	0.00421	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC26A1—nephrolithiasis	6.83e-05	0.00421	CbGpPWpGaD
Indapamide—CA4—Metabolism—AGXT—nephrolithiasis	6.41e-05	0.00395	CbGpPWpGaD
Indapamide—CA2—Metabolism—AGXT—nephrolithiasis	6.14e-05	0.00378	CbGpPWpGaD
Indapamide—CA9—Metabolism—GRHPR—nephrolithiasis	5.81e-05	0.00358	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AQP1—nephrolithiasis	5.63e-05	0.00347	CbGpPWpGaD
Indapamide—CA4—Metabolism—APRT—nephrolithiasis	5.45e-05	0.00336	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC26A1—nephrolithiasis	5.45e-05	0.00336	CbGpPWpGaD
Indapamide—CA7—Metabolism—AQP1—nephrolithiasis	5.25e-05	0.00324	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AQP1—nephrolithiasis	5.25e-05	0.00324	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC26A1—nephrolithiasis	5.22e-05	0.00322	CbGpPWpGaD
Indapamide—CA2—Metabolism—APRT—nephrolithiasis	5.22e-05	0.00322	CbGpPWpGaD
Indapamide—CA9—Metabolism—AGXT—nephrolithiasis	5.18e-05	0.00319	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CHRM3—nephrolithiasis	5.09e-05	0.00314	CbGpPWpGaD
Indapamide—CA12—Metabolism—AQP1—nephrolithiasis	4.87e-05	0.003	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CHRM3—nephrolithiasis	4.75e-05	0.00293	CbGpPWpGaD
Indapamide—CA7—Metabolism—CHRM3—nephrolithiasis	4.75e-05	0.00293	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC26A1—nephrolithiasis	4.4e-05	0.00271	CbGpPWpGaD
Indapamide—CA9—Metabolism—APRT—nephrolithiasis	4.4e-05	0.00271	CbGpPWpGaD
Indapamide—CA12—Metabolism—CHRM3—nephrolithiasis	4.4e-05	0.00271	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	4.33e-05	0.00267	CbGpPWpGaD
Indapamide—CA4—Metabolism—AQP1—nephrolithiasis	3.88e-05	0.00239	CbGpPWpGaD
Indapamide—CA2—Metabolism—AQP1—nephrolithiasis	3.72e-05	0.00229	CbGpPWpGaD
Indapamide—CA4—Metabolism—CHRM3—nephrolithiasis	3.51e-05	0.00216	CbGpPWpGaD
Indapamide—CA2—Metabolism—CHRM3—nephrolithiasis	3.36e-05	0.00207	CbGpPWpGaD
Indapamide—CA9—Metabolism—AQP1—nephrolithiasis	3.14e-05	0.00193	CbGpPWpGaD
Indapamide—CA9—Metabolism—CHRM3—nephrolithiasis	2.84e-05	0.00175	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GRHPR—nephrolithiasis	9.78e-06	0.000602	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.71e-06	0.000537	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APRT—nephrolithiasis	7.41e-06	0.000457	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	7.41e-06	0.000457	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AQP1—nephrolithiasis	5.28e-06	0.000325	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.77e-06	0.000294	CbGpPWpGaD
